Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Nvsef crawled date : 2022 - 04 - 06 save search
Global Cancer Immunotherapy Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
Published: 2022-04-06 (Crawled : 19:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 4.21%
H: 0.0%
C: -0.61%
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 1.45%
H: 0.46%
C: 0.19%
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 1.98%
H: 0.0%
C: -1.11%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.39%
H: 0.53%
C: 0.44%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 1.15%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 1.01%
H: 0.0%
C: 0.0%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.27%
H: 2.95%
C: 1.12%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: 0.05%
H: 2.52%
C: 2.49%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.74%
H: 0.0%
C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 0.35%
H: 2.64%
C: 2.45%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -0.29%
H: 1.42%
C: 0.98%
immunotherapy cancer market
Sandoz extends collaboration agreement to drive cutting-edge digital solutions in global fight against antimicrobial resistance (AMR)
Published: 2022-04-06 (Crawled : 06:00) - globenewswire.com
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 0.37%
H: 0.06%
C: 0.06%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.78%
H: 2.05%
C: 2.01%
solutions collaboration
FDA approves Novartis Vijoice® (alpelisib) as first and only treatment for select patients with PIK3CA-Related Overgrowth Spectrum (PROS)
Published: 2022-04-06 (Crawled : 01:00) - globenewswire.com
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 0.37%
H: 0.06%
C: 0.06%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.78%
H: 2.05%
C: 2.01%
vijoice treatment fda novartis
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.